Category

🎙 Leader Talks

30 results
Are We Building Pharma Plants Too Fast and Paying for It Later? Leader Talks 8 MIN
LEADER TALKS

Are We Building Pharma Plants Too Fast and Paying for It Later?

Lessons in Engineering, Compliance, and Scale-Up. inConversation with Mr Abhay Inamdar Across the pharmaceutical industry, the pressure to build faster has never been higher.…

ET Editorial Team MAY 19
From Cost Center to Strategic Asset – Role of APIs in Global Pharma Value Chains Leader Talks 7 MIN
LEADER TALKS

From Cost Center to Strategic Asset – Role of APIs in Global Pharma Value Chains

API operations are no longer viewed only through the lens of cost and supply. In today’s environment of heightened regulatory scrutiny, complex development requirements,…

ET Editorial Team MAY 1
Net-Zero in Pharma: Balancing Molecules, Mandates, and Material Reality Leader Talks 6 MIN
LEADER TALKS

Net-Zero in Pharma: Balancing Molecules, Mandates, and Material Reality

By Shankari Swaminathan | Spectrum “Net-zero by 2040.”“Carbon-neutral operations.” These commitments now populate annual reports, investor decks, and ESG disclosures across the global pharmaceutical…

ET Editorial Team APR 14
Unlocking CDMO Insights with Annette Boland CDMO 7 MIN
CDMO

Unlocking CDMO Insights with Annette Boland

Pharmaceutical companies increasingly rely on Contract Development and Manufacturing Organizations (CDMOs) to bring efficiency, flexibility, and innovation to their operations. As partnerships with CDMOs…

ET Editorial Team APR 2
A Lifetime of Quality Excellence Captured in “Quality Trailblazer: CGMP to Quality Maturity” Leader Talks 3 MIN
LEADER TALKS

A Lifetime of Quality Excellence Captured in “Quality Trailblazer: CGMP to Quality Maturity”

A Book by Mr. Ranjit Barshikar The pharmaceutical industry is built on an invisible promise, a promise that every medicine reaching a patient is…

ET Editorial Team APR 2
How Pharma 4.0 Is Redefining Quality, Speed, and Decision-Making. Leader Talks 7 MIN
LEADER TALKS

How Pharma 4.0 Is Redefining Quality, Speed, and Decision-Making.

Compliance Is No Longer the Goal, It Is the Byproduct inConversation with Mr Sekhar Surabhi As pharmaceutical manufacturing transitions from static, batch-driven paradigms to…

ET Editorial Team MAR 31
Designing for Scale: Reimagining Manufacturability as the First Principle of Pharmaceutical Innovation Leader Talks 9 MIN
LEADER TALKS

Designing for Scale: Reimagining Manufacturability as the First Principle of Pharmaceutical Innovation

inConversation with Dr Padmanabha RV Reddy In an era where pharmaceutical innovation is increasingly defined not just by molecular breakthroughs but by the ability…

ET Editorial Team MAR 24
Building the Connected Pharmaceutical Ecosystem Leader Talks 9 MIN
LEADER TALKS

Building the Connected Pharmaceutical Ecosystem

inConversation with Mr Harpal Singh As pharmaceutical manufacturing transitions into a more connected and data intensive era, the integration of digital factory platforms and…

ET Editorial Team MAR 12
Regulatory Convergence or Fragmentation? Leader Talks 6 MIN
LEADER TALKS

Regulatory Convergence or Fragmentation?

Global API regulatory compliance, and what global API players must prepare for next As global API manufacturers navigate an increasingly complex regulatory landscape, the…

ET Editorial Team JAN 9
Turning AI from buzzword to backbone AI in Pharmaceutical Manufacturing 10 MIN
AI IN PHARMACEUTICAL MANUFACTURING

Turning AI from buzzword to backbone

In conversation with Sujit Janardanan, Chief Marketing Officer – Neysa Sujit Janardanan has spent over 20 years building and leading marketing functions for some…

ET Editorial Team AUG 22